PA
FURX

Perceptive Advisors’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Perceptive Advisors’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-5,000
Closed -$220K – 150
2013
Q3 		$220K Buy
+5,000
New +$207K 0.02% 86

Other funds holding FURX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Perceptive Advisors's FURX Position: Q4 2013 in Review

Perceptive Advisors sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q4 2013, closing a stake of 5,000 shares — an estimated $220K sold.

Perceptive Advisors first reported a position in FURX in Q3 2013 and held it in 1 quarter. The position peaked at $220K in Q3 2013. 84 funds tracked by Wall St. Rank hold FURX as of Q4 2013.

  • Perceptive Advisors reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q4 2013 after selling out during the quarter.
  • Perceptive Advisors sold 5,000 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q4 2013, an estimated $220K.
  • Perceptive Advisors first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 1 quarter.
  • Perceptive Advisors's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $220K in Q3 2013.
  • 84 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q4 2013.

Based on Perceptive Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.